Orca Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference

MENLO PARK, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Orca Bio, a clinical-stage biotechnology company developing high-precision cell therapies for patients with blood diseases, today announced that Ivan Dimov, Ph.D., Chief Executive Officer, will present a company overview at the 39th Annual J.P. Morgan Healthcare Conference. The presentation will be held virtually on Monday, January 11, 2021, at 1:55 p.m. PT (4:55 p.m. ET), immediately followed by a Q&A session.

Click to view original post